ABBOTT LABORATORIES — Director's Dealing 2007

Feb 20, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-15

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-15	Common shares without par value	F	7101	$52.70	Disposed	82840	Direct
2007-02-16	Common shares without par value	A	20400	$52.54	Acquired	103240	Direct
2007-02-16	Common shares without par value	A	17000	$52.54	Acquired	120240	Direct
2007-02-17	Common shares without par value	F	3486	$52.49	Disposed	116754	Direct
2007-02-18	Common shares without par value	F	1222	$52.49	Disposed	115532	Direct
2007-02-20	Common shares without par value	F	1776	$52.49	Disposed	113756	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-16	Option (right to buy)	$52.54	A	83000	Acquired	2017-02-15	Common shares (83000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15224	Indirect
Common shares without par value	25000	Indirect
Common shares without par value	875	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2007

F4: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F5: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-11.

F6: Reporting person disclaims beneficial ownership of all securities held by his son.

F7: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/16/2008, 27,667 on 02/16/2009 and 27,666 on 02/16/2010.